NCT04616196 2025-06-08Study of NKTR 255 in Combination With Cetuximab in Solid TumorsNektar TherapeuticsPhase 1/2 Completed25 enrolled 17 charts
NCT04136756 2023-06-15NKTR-255 in Relapsed/Refractory Multiple Myeloma & Non-Hodgkin LymphomaNektar TherapeuticsPhase 1 Completed30 enrolled